3',4',6'-Triacetate 2'-Deoxy-2-methyl-4,5-D-galactopyrano-Δ2-oxazoline - CAS 10378-06-0
Catalog: |
BB057694 |
Product Name: |
3',4',6'-Triacetate 2'-Deoxy-2-methyl-4,5-D-galactopyrano-Δ2-oxazoline |
CAS: |
10378-06-0 |
Synonyms: |
(3aR,5R,6R,7R,7aR)-5-(Acetoxymethyl)-2-methyl-3a,6,7,7a-tetrahydro-5H-pyrano[3,2-d]oxazole-6,7-diyl Diacetate |
IUPAC Name: | [(3aR,5R,6R,7R,7aR)-6,7-diacetyloxy-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]oxazol-5-yl]methyl acetate |
Description: | 3',4',6'-Triacetate 2'-Deoxy-2-methyl-4,5-D-galactopyrano-╬Ф2-oxazoline is an intermediate in the synthesis of 2-[[3,4,6-Tri-O-acetyl-2-(acetylamino)-2-deoxy-b-D-galactopyranosyl]oxy]acetic Acid (T992240), a therapeutic antisense oligonucleotide agent targeting gene G6PC cDNA for glycogen storage disease type Ia. |
Molecular Weight: | 329.31 |
Molecular Formula: | C14H19NO8 |
Canonical SMILES: | CC1=NC2C(C(C(OC2O1)COC(=O)C)OC(=O)C)OC(=O)C |
InChI: | InChI=1S/C14H19NO8/c1-6-15-11-13(22-9(4)18)12(21-8(3)17)10(5-19-7(2)16)23-14(11)20-6/h10-14H,5H2,1-4H3/t10-,11-,12+,13-,14+/m1/s1 |
InChI Key: | WZFQZRLQMXZMJA-RGDJUOJXSA-N |
Solubility: | Chloroform (Sparingly), DMSO (Slightly), Methanol (Slightly) |
Appearance: | Light Yellow to Yellow Thick Oil |
Storage: | 4°C, Inert atmosphere |
References: | Koizumi, M., et al. PCT Int. Appl. 278pp. (2019). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2022040487-A1 | Triptolide conjugates and uses thereof | 20200821 |
WO-2021156792-A1 | Targeted plasma protein degradation | 20200207 |
WO-2021044004-A1 | Oligonucleotides containing nucleotide analogs | 20190905 |
WO-2020191183-A1 | Multivalent ligand clusters for targeted delivery of therapeutic agents | 20190321 |
AU-2020242043-A1 | Multivalent ligand clusters for targeted delivery of therapeutic agents | 20190321 |
EP-3923989-A1 | Multivalent ligand clusters for targeted delivery of therapeutic agents | 20190321 |
WO-2020093061-A1 | Therapeutic methods | 20181102 |
AU-2019370563-A1 | Therapeutic methods | 20181102 |
EP-3873530-A1 | Therapeutic methods | 20181102 |
US-2022031847-A1 | Therapeutic methods | 20181102 |
Complexity: | 531 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 5 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 329.11106656 |
Formal Charge: | 0 |
Heavy Atom Count: | 23 |
Hydrogen Bond Acceptor Count: | 9 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 329.11106656 |
Rotatable Bond Count: | 7 |
Topological Polar Surface Area: | 110Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.5 |
-
Catalog: BB016437
2-amino-3-{pyrrolo[2,1-f][1,2,4]triazin-5-yl}propanenitrile
Detail
-
Catalog: BB002009
Ethylenesulfate
Detail
-
Catalog: BB014333
[2-(trifluoromethyl)oxan-4-yl]methanamine
Detail
-
Catalog: BB016397
1-methyl-3-(1,3-thiazol-2-yl)-1H-pyrazole-5-carbaldehyde
Detail
-
Catalog: BB012200
8-(tetramethyl-1,3,2-dioxaborolan-2-yl)-4H-chromen-4-one
Detail
-
Catalog: BB077194
(S)-(-)-1,2-epoxydecane
Detail
-
Catalog: BB076899
Cucurbit[5]uril
Detail
-
Catalog: BB016398
4-chloro-6-methylimidazo[2,1-f][1,2,4]triazine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS